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ABSTRACT 
New series of N (2-alkyl/aryl-5-oxo-imidazolidine-1-yl) isonicotinamide derivatives were synthesized by the reaction of Schiff base 
with amino acetic acid in the presence of 1:4 dioxane. Synthesized compounds were evaluated for their Anti-bacterial activity 
against Staphylococcus aureus and Echerichia coli, Antifungal activity against Candida Albicans and Anti-tubercular activity 
against Mycobacterium tuberculosis. Synthesized compounds show significant activity against bacterial, fungal and mycobacterium 
strains. Their structures were established on the basis of elemental analysis, IR, 1H NMR and Mass Spectral data.      
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INTRODUCTION:  
Antimicrobial agents act against microbial organisms 
and inhibit their growth and reproduction. Antibiotics 
and antimicrobial term used synonymously but there is a 
difference between both the terms. Antibiotic refers to 
substances produced by microorganisms that act against 
another microorganism where antimicrobial agent may 
be synthetic. Thus, antibiotics do not include 
antimicrobial substances that are synthetic (sulfonamides 
and quinolones), or semisynthetic (methicillin and 
amoxicillin), or those which come from plants (quercetin 
and alkaloids) or animals (lysozyme)
1
. Microbial 
infection is the major cause of death in the world, 
although deaths from bacterial and fungal infection have 
dropped currently. Natural, synthetic and semi synthetic 
antimicrobial agents have been used since a long time 
against the life threatening infectious diseases 
2
. 
Although deaths from bacterial and fungal infection 
have dropped currently, still those are the major cause of 
death in the world. Over the few past decades the 
bacterial resistance to antibiotics, anti-fungal and anti-
tuberculotic drugs has become one of the most 
challenging problem in the infections treatments. 
Tuberculosis (TB) is the world’s oldest known infectious 
disease that kills three million deaths each year
3
. 
MATERIAL AND METHOD: 
All the chemicals used were purchased from E Merck, S 
D Fine and Loba Chem and were purified by established 
methods (whenever needed). Various Substituted 
Isoniazid (Schiff Base) derivatives were prepared 
according to the procedure outline in scheme-I. 
imidazolidine derivatives were synthesized by formation 
of imines (from Schiff base) and ketenes (from amino 
acetic acid) followed by cycloaddition of ketenes to 
imines, in the presence of 1:4 Dioxane, in a single step 
reaction. Melting points were determined by open 
capillary tube method and are uncorrected. Purity of 
synthesized compounds was checked by TLC plates 
(Silica Gel G) and visualized by iodine vapor. The infra 
red absorption spectra of the synthesized compounds 
were recorded using KBr disc on FTIR 8010 Shimadzu 
model. 1H NMR spectra were recorded on Brucker 
Spectrospin DPX 300 spectrophotometer. Mass spectra 
were recorded on Jeol SR-102 FAB Mass spectrometer. 
CHN analyses of synthesized compounds were done on 
Perkin-Elmer-240 analyzer
4
. 
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1(a-f) 
 
N (2-alkyl/aryl-5-oxo-imidazolidine-1-yl) 
isonicotinamide (2a-f) 
 
Part A: Synthesis of various Schiff Bases by the 
reaction of isoniazid with substituted aldehydes     
Part B: Synthesis of N-(5-oxo-2-alkyl/aryl 
imidazolidine-1-yl) isonicotinamide derivatives 
 
Mechanism of reactions involved in synthesis of titled 
compounds 
Part A: It involves synthesis Schiff Bases by the reaction 
of isoniazid and substituted carbonyl compounds which 
proceeds in two steps; 1) Nucleophilic addition forming 
unstable hemiaminal intermediates and 2) Hemiaminal 
intermediate formation followed by dehydration to form 
Schiff Bases (imines). 
Part B: This part of synthesis of titled compounds is 
attributed to synthesis of N-(5-oxo-2-alkyl/aryl-
imidazolidine-1-yl) isonicotinamide derivatives, 2 (a-f)
 
 
The stepwise reaction mechanism is as follows: 
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Table 1: Physical Characteristics of synthesized compounds: 
Comp. R1 R2 
Molecular 
Weight 
Yield (%) 
Melting Point 
(°C) 
Rf Value 
2a CH3 C6H5 296.32 1.95gm (65.88%) 215-7 0.7 
2b C6H5 C6H5 358.39 2.46gm (68.72%) 242-4 0.7 
2c 
 
H 272.26 1.56gm (57.35%) 276-8 0.7 
2d 
 
H 283.29 1.74gm (61.48%) 275-7 0.5 
2e 
 
H 321.33 2.17gm (67.60%) 276-8 0.8 
2f 
 
H 288.33 1.83gm (63.54%) 244-6 0.8 
 
General Procedure for Synthesis of substituted 
isoniazid, (Schiff Base) 1(a-f): 
In a round bottomed flask, isoniazid (0.1mol), 
substituted aldehyde (0.1mol) and ethanol (30-35 ml) 
was taken and refluxed for three hours. The solution was 
cooled at room temperature and allowed to stand for 5 
hours. Solid product was separated out, filtered, washed 
with ice cooled distilled water, dried and recrystalised 
with ethanol.  
General procedure for synthesis of N-(2-mehtyl-5-
oxo-imidazolidine-1-yl)isonicotinamide, 2(a-f) 
0.01 mol of substituted isoniazid 1(a-f) (Schiff Base) 
and amino acetic acid (0.75gm, 0.01 mol) was dissolved 
in 1:4 dioxane (25ml) with constant stirring. The content 
was transferred to round bottom flask and heated under 
reflux for 5 hours. The mixture was allowed to cool at 
room temperature. The solid product was filtered, 
washed with ice cold water, dried and recrystalised from 
ethanol.  
Compound 2a: IR (KBr, Cm
-1
) 3390 (N-H Stre. 
Secondary Amide), 3350 (N-H Stre imidazolidine), 
3040 (Aromatic -C-H Stre.), 1660 (C-N Stre pyridine 
ring), 1610 (acyclic C=O stre.), 1490 (CH2 bend.), 1420 
(CH3), 1340 (C-NH imidazolidine). H
1
 NMR (DMSO-d6 
δ ppm): 9.6 (m, 1H NH cyclic), 8.1 (s, 1H, NH amide), 
7.6-7.8 (m, 4H, CH pyridine), 7.2 (m, 5H, aromatic H), 
3.3 (d, 2H, -CH2- aromatic), 2.2 (s, 3H, CH3). Mass 
Peaks: 296.7 (M
+
), 219.5, 204.7, 121.1, 84.7, 78.1.  
Elemental analysis% found: C-64.85%, H-5.44 %, N-
17.69%  
Compound 2b:  IR (KBr, Cm
-1
) 3390 (N-H Stre. 
Secondary Amide), 3350 (N-H Stre imidazolidine), 
3050 (Aromatic -C-H Stre.), 1660 (C-N Stre pyridine 
ring), 1610 (acyclic C=O stre.), 1490 (CH2 bend.), 1340 
(C-NH imidazolidine). H
1
 NMR (DMSO-d6 δ ppm): 9.6 
(m, 1H NH cyclic), 8.1 (s, 1H, NH amide), 7.6-7.8 (m, 
4H, CH pyridine), 6.9-7.6 Mass Peaks: 358.7 (M
+
), 
281.5, 204.7, 121.1, 84.7, 78.1. Elemental analysis% 
found: C-70.31%, H5.06 %, N-15.62%  
Compound 2c:  IR (KBr, Cm
-1
) 3390 (N-H Stre. 
Secondary Amide), 3350 (N-H Stre imidazolidine), 
3050 (Aromatic -C-H Stre.), 1660 (C-N Stre pyridine 
ring), 1610 (acyclic C=O stre.), 1490 (CH2 bend.), 1420 
(CH3), 1340 (C-NH imidazolidine), 1310 (cyclic C-O 
Stre). H
1
 NMR (DMSO-d6 δ ppm):9.6 (1H NH cyclic), 
8.1 (1H, NH amide), 7.6-7.8 (4H, CH pyridine), 5.8 (3H 
furfural), 3.3 (2H, -CH2 - aromatic), 2.5 (1H, aromatic –
CH-). Mass Peaks: 272.3 (M
+
), 205.8, 121.1, 84.7, 78.1. 
Elemental analysis% found: C-57.35%, H 4.44 %, N-
20.58%  
Compound 2d: IR (KBr, Cm
-1
) 3390 (N-H Stre. 
Secondary Amide), 3350 (N-H Stre imidazolidine), 
3050 (Aromatic -C-H Stre.), 1660 (C-N Stre pyridine 
ring), 1610 (acyclic C=O stre.), 1490 (CH2 bend.), 1420 
(CH3), 1340 (C-NH imidazolidine). H
1
 NMR (DMSO-d6 
δ ppm) 9.6 (1H NH cyclic), 8.1 (1H, NH amide), 7.6-7.8 
(8H, CH pyridine), 3.3 (2H, -CH2 - aromatic), 2.5 (1H, 
aromatic –CH-). Mass Peaks: 283.4 (M+), 205.8, 121.1, 
84.7, 78.1. Elemental analysis% found: C-59.36%, H 
4.63 %, N-24.72%  
Compound 2e: IR (KBr, Cm
-1
) 3390 (N-H Stre. 
Secondary Amide), 3350 (N-H Stre imidazolidine), 
3050 (Aromatic -C-H Stre.), 1660 (C-N Stre pyridine 
ring), 1610 (acyclic C=O stre.), 1490 (CH2 bend.), 1420 
(CH3), 1340 (C-NH imidazolidine), 790 (N-H wag). H
1
 
NMR (DMSO-d6 δ ppm) 9.6 (1H NH cyclic), 8.1 (1H, 
NH amide), 7.7-7.8 (4H, CH pyridine), 7.6 (4H, CH 
benzene), 7.2 (1H NH indole), 6.4 (1H, CH pyrole), 3.3 
(2H, -CH2 - aromatic), 2.5 (1H, aromatic –CH-). Mass 
Peaks: 321.2 (M
+
), 205.7, 121.1, 84.7, 78.1. Elemental 
analysis% found: C-63.54%, H 4.71%, N-21.79%  
Compound 2f: IR (KBr, Cm
-1
) 3390 (N-H Stre. 
Secondary Amide), 3350 (N-H Stre imidazolidine), 
3050 (Aromatic -C-H Stre.), 1660 (C-N Stre pyridine 
ring), 1610 (acyclic C=O stre.), 1490 (CH2 bend.), 1420 
(CH3), 1350 (C-NH imidazolidine), 1310 (C-S Stre). H
1
 
NMR (DMSO-d6 δ ppm) 9.6 (1H NH cyclic), 8.1 (1H, 
NH amide), 7.7-7.8 (4H, CH pyridine), 7.2-7.3 (3H, CH 
thiophene), 3.3 (2H, -CH2 - aromatic), 2.5 (1H, aromatic 
–CH-). Mass Peaks: 288.5 (M+), 205.8, 121.1, 84.7, 
O
N
N
H
 
S
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78.1.  Elemental analysis% found: C-54.15%, H 4.20%, 
N-19.43%  
Antimicrobial Activity All the synthesized compounds 
were evaluated for their invitro antimicrobial activity 
against gram positive bacteria staphylococcus aureus 
(ATCC-24392), the gram negative bacteria Echerichia 
coli (ATCC-24391) in nutrient agar media, fungi C 
Albicans (ATCC-436) in sabouraud dextrose medium 
and mycobacterium tuberculosis (ATTC-27286) in 
tween-albumin medium. The zone of inhibition values 
were determined and compared with well known 
(standard) antibacterial (Ofloxacin), antifungal 
(Ketoconazole) and antituberculotic (Isoniazid) drugs.  
Table: 2 shows data obtained from the biological 
screening of synthesized compounds and reference 
drugs.
  
Table 2: Antimicrobial screening data of compounds 2a-2f. 
Compounds 
Zone of Inhibition (in mm) at concentration of 20 µg/mL) 
S. aureus E. Coli C. Albicans M. tuberculosis 
2a 17 19 23 28 
2b 18 19 24 31 
2c 19 20 32 32 
2d 23 22 28 29 
2e 25 27 31 34 
2f 19 19 27 31 
Ofloxacin 17 19 ----- ----- 
Ketoconazole  ----- ----- 25 ----- 
Isoniazid  ----- ----- ----- 28 
 
RESULTS AND DISCUSSION:  
Yield of synthesized compounds were found to be 
satisfactory. The purity of synthesized compounds and 
completion of reactions were checked by TLC on silica 
Gel G plates in the solvent system methyl chloride: 
methanol (8:2 v/v) and visualized spots in iodine vapor. 
Proposed structures were confirmed by Spectral and 
microanalysis data. IR spectra showed presences of 
various functional groups that were further supported by 
the H
1
 NMR and Mass spectral data. Furthermore 
elemental analysis data were also found in agreement 
with calculated values from proposed structures. 
Antibacterial, antifungal and anti tuberculotic screening 
data of synthesized compounds showed good to 
moderate activity as compared to reference drug. 
Compound 2c and 2d showed moderate and 2b, and 2e 
showed good activity against tested strains. Amongst 
these compounds 2e showed best antibacterial, 
antifungal and anti tuberculotic activity against all 
strains. The antimicrobial potency of synthesized 
compounds is due the presence of pharmacological 
active isonicotinamide moiety and increased by the 
addition of imidazolidine moiety.  
CONCLUSION:  
On the basis of above research work; the results and 
discussion showed that the synthesized compounds 
showed good antimicrobial activity as compared to 
reference antimicrobial drugs. These results concluded 
the need of development of such type of compounds in 
future for the progress of drug synthesis area. 
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